Stocktoria
National Vision Holdings, Inc. EYE
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 2017-10-26
Chart by TradingView
7/9
Piotroski F — financial health
0.82
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $2.0B | $1.8B | $1.8B | $1.6B | $2.1B |
| Operating income | $58.8M | -$10.4M | $24.5M | $52.8M | $174.9M |
| Net income | $29.6M | -$28.5M | -$65.9M | $42.1M | $128.2M |
| Operating cash flow | $146.3M | $133.6M | $173.0M | $119.2M | $258.9M |
| Free cash flow | $73.5M | $38.1M | $58.3M | $5.7M | $163.4M |
| Total assets | $2.0B | $2.0B | $2.2B | $2.3B | $2.3B |
| Shareholders' equity | $869.5M | $816.3M | $829.4M | $901.1M | $926.0M |
| Ratios | |||||
| Operating margin | 3.0% | -0.6% | 1.4% | 3.2% | 8.4% |
| Net margin | 1.5% | -1.6% | -3.8% | 2.6% | 6.2% |
| FCF margin | 3.7% | 2.1% | 3.3% | 0.3% | 7.9% |
| Return on assets | 1.5% | -1.4% | -3.0% | 1.8% | 5.6% |
| Return on equity | 3.4% | -3.5% | -7.9% | 4.7% | 13.8% |
| Debt / equity | 0.26× | 0.41× | 0.54× | 0.61× | 0.59× |
| Current ratio | 0.55 | 0.53 | 1.00 | 1.38 | 1.50 |
| Revenue growth | 9.0% | 3.8% | 6.8% | -20.9% | 21.5% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 611,700 | $15.8M |
| Bridgewater Associates, LP | 26,517 | $686,790 |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.82 (distress)
- Working capital / assets -0.094
- Retained earnings / assets 0.129
- EBIT / assets 0.03
- Equity / liabilities 0.78
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001710155 · as of 2026-01-03. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.